A subscription to JoVE is required to view this content. Sign in or start your free trial.

Research Article

Neuronal Ferroptosis Attenuation by RKIP Inhibition Following Spontaneous Intracerebral Hemorrhage via NRF2/HO-1 Pathway Activation

468 views

⸱

DOI:

10.3791/68511

⸱

October 31st, 2025

In This Article

Summary

By conducting both organismal and cell culture-based studies, it was demonstrated that inhibiting Raf kinase inhibitor protein (RKIP) can mitigate neuronal ferroptosis following spontaneous intracerebral hemorrhage, thereby reducing brain injury. The observed cytoprotection arises through NRF2/HO-1 signaling axis modulation.

Abstract

Raf kinase inhibitor protein (RKIP), a primary member of the phosphatidylethanolamine-binding protein family, is recognized for its involvement in various physiological processes, including cell differentiation, migration, cell cycle, and apoptosis. This study explored its function in neuronal ferroptosis following spontaneous intracerebral hemorrhage (ICH) and the associated mechanisms. A cellular model of spontaneous ICH was developed using cultured rat pheochromocytoma (PC12) cells stimulated with hemin. Cell viability, RNA expression, reactive oxygen species (ROS) levels, and lipid hydroperoxide (LPO) were assessed. Additionally, protein expression levels were measured. This study confirmed that RKIP inhibition is neuroprotective in vitro following ICH. This effect was associated with increased expression of glutathione peroxidase 4 (GPX4) and decreased expression of acyl-CoA synthetase long-chain family 4 (ACSL4), along with ROS and LPO levels in neurons. RKIP inhibition demonstrated a protective role against neuronal ferroptosis in vitro following ICH, potentially via activation of the nuclear factor E2-related factor 2/heme oxygenase-1 (NRF2/HO-1) pathway. This mechanism may offer insights into therapeutic strategies targeting neuronal ferroptosis in ICH.

Introduction

Spontaneous intracerebral hemorrhage (ICH) is a cerebrovascular condition characterized by bleeding due to intracranial vascular damage, necrosis, and vessel rupture, commonly affecting the basal ganglia and representing a major subtype of hemorrhagic stroke1. The mortality rate among patients diagnosed with ICH is approximately 50%, and a significant proportion of survivors experience severe loss of independence2. Current treatment options for spontaneous ICH are limited, with no existing therapies shown to significantly reduce mortality or markedly enhance neurological outcomes post-ICH.

Ferroptosis, an iron-dependent form of programmed cell death, is defined by lipid peroxidation, accumulation of ferrous ions, and depletion of glutathione, distinguishing it from other forms of programmed cell death in genetic, morphological, and biological terms3. Increasing evidence highlights the role of neuronal ferroptosis in the pathology of ICH. Raf kinase inhibitor protein (RKIP), also known as phosphatidylethanolamine-binding protein 1 (PEBP1), is involved in neural development and forms the 15LOX/PEBP1 complex through its binding with 15-lipoxygenase (15LOX), a key regulator of ferroptosis4. However, the specific role and mechanisms of RKIP in ferroptosis linked to the progression of spontaneous ICH remain unexplored.

This study examined the anti-ferroptosis effects of RKIP inhibition on neurons, demonstrating that inhibition of RKIP expression could suppress neuronal ferroptosis following ICH, potentially through activation of the nuclear factor E2-related factor 2/heme oxygenase-1 (NRF2/HO-1) pathway. These findings are significant for the development of novel therapeutic strategies targeting the pathogenesis of ICH.

Access restricted. Please log in or start a trial to view this content.

Protocol

Culture of PC12 cells
The PC12 cell line was propagated in Roswell Park Memorial Institute 1640 (RPMI-1640) growth medium containing 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin, with routine maintenance under standard culture conditions (37 °C, 5% CO2 humidified atmosphere). For experimental procedures, adherent cells were plated onto culture vessels and allowed to proliferate until achieving near-confluent monolayers (approximately 90% surface coverage). Cellular dissociation was accomplished through enzymatic treatment using 0.25% trypsin-EDTA solution, followed by three successive subculturing cycles to ensure population stability. Processed cells were subsequently allocated for downstream experimental applications and analytical assessments.

Cell viability assays
Cell viability was assessed to evaluate the cytotoxicity of hemin and Locostatin on PC12 cells, following the instructions provided by the assay kit's manufacturer. PC12 cells were uniformly seeded in 96-well plates and cultured with hemin or Locostatin for 24 h. Following washing with phosphate-buffered saline (PBS), the cells were incubated in RPMI-1640 medium containing 10% tetrazolium salt solution for 90 min at 37 °C. Optical Density (OD) values were then measured at 450 nm using a microplate reader.

Quantitative reverse transcription-polymerase chain reaction (RT-qPCR)
Total RNA was extracted from PC12 cells using the RNA extraction reagent. First, the sample was homogenized in the extraction reagent, ensuring thorough lysis. Chloroform was added to the mixture, shaken vigorously, and centrifuged to separate the phases (12,000 × g, 15 min, 4 °C). The aqueous phase containing the RNA was collected, and the RNA was precipitated by adding isopropanol (aqueous phase : iPrOH = 1:1) and incubating at room temperature. Centrifugation was done to pellet the RNA (12,000 × g, 10 min, 4 °C), 1 mL of 70% ethanol was added to remove impurities, and finally, the RNA pellet was dissolved in RNase-free water for storage at -80 °C. Complementary DNA (cDNA) templates were generated by reverse transcription with the RT Master Mix. The resulting templates were then diluted at a 1:5 ratio and subjected to quantitative real-time PCR on a real-time PCR instrument. Each sample was amplified in triplicate, and the relative amount of PCR product was averaged. The primers used are listed in Table 1, with β-actin serving as the housekeeping gene. Relative mRNA concentration was determined using the formula E = 2−ΔΔCt, and the Critical Threshold Cycle (CT) Value was recorded for each reaction.

Intracellular reactive oxygen species (ROS) and lipid hydroperoxide (LPO) assays
ROS and LPO levels were measured using flow cytometry. PC12 cells were treated with hemin (80 µM), Locostatin (5 µM), and ML385 (5 µM) for 24 h and washed 3x with PBS in dishes. The cells were then incubated at 37 °C with 5% CO2 for 40 min in the presence of 2',7'-dichlorodihydrofluorescein diacetate (DCFH-DA), a ROS probe, and BODIPY 581/591 C11, an LPO probe. Following PBS washes to remove excess probes, fluorescence intensity was measured by flow cytometry. A consistent gating strategy was applied across all samples: first, cells were gated on FSC-A vs. SSC-A to exclude debris, then, single cells were selected by FSC-A vs. FSC-H gating. Unstained cells and cells treated with hemin alone were used as negative and positive controls to establish the fluorescence compensation and gates. Data were analyzed using the linked software.

Protein extraction and western blot
Total protein extraction 
The supernatant of treated PC12 cells was discarded, followed by three washes with ice-cold PBS. Cells were harvested using trypsin and centrifuged at 200 × g for 5 min. After removing the supernatant, the cell pellet was homogenized in cold Radio-Immunoprecipitation Assay (RIPA) lysis buffer containing 10% protease inhibitor and 10% phosphatase inhibitor. After a 30 min incubation on ice, the lysate was centrifuged at 12,000 × g for 15 min at 4 °C. The clear supernatant was mixed with Loading Buffer (4:1) and heated at 95 °C for 5 min to denature proteins. Protein samples were stored at -80 °C for subsequent use.

Western blot analysis 
Proteins were separated by SDS-PAGE using a stacking gel and resolving gel, with samples loaded into wells. Electrophoresis was performed at 80 V for the stacking gel and 120 V for the resolving gel. Proteins were transferred onto a polyvinylidene fluoride (PVDF) membrane (pre-activated in methanol for 1 min) using a transfer system at a constant current of 300 mA for 1-2 h. The membrane was blocked with 5% skim milk in TBST for 2 h at room temperature to prevent nonspecific binding. After three washes with TBST (10 min each), the membrane was incubated overnight at 4 °C with the following primary antibodies diluted in TBST: Rabbit anti-ACSL4 (1:1,000), Rabbit anti-GPX4 (1:1,000), Rabbit anti-HO-1 (1:2,000), Rabbit anti-NRF2 (1:1,000), Rabbit anti-RKIP (1:1,500), and Mouse anti-β-actin (1:5,000). The membrane was washed for 3 x 10 min with TBST and incubated with HRP-conjugated secondary antibodies for 2 h at room temperature: HRP-labeled Goat Anti-Mouse IgG (1:1,000), HRP-labeled Goat Anti-Rabbit IgG (1:1,000). After additional TBST washes for 3 x 5 min, protein signals were visualized using an ECL Western Blot Kit and quantified using ImageJ software.

Immunofluorescence staining
Cells were seeded onto coverslips pre-placed in culture plates and allowed to adhere. After experimental treatments, the supernatant was discarded, and cells were washed 3x with PBS. Cells were fixed with 4% paraformaldehyde (PFA) for 15 min at room temperature, followed by three PBS washes. Subsequently, cells were permeabilized with 0.1% Triton X-100 for 10 min at room temperature and washed 3x with PBS. Nonspecific binding was blocked by incubating with 3% bovine serum albumin (BSA) for 30 min at room temperature. Primary antibodies were applied overnight at 4 °C: Rabbit anti-HO-1 (1:500), Rabbit anti-NRF2 (1:500). After three PBS washes the next day, cells were incubated with fluorescent secondary antibodies in the dark for 1 h at room temperature: Alexa Fluor 488-labeled Goat Anti-Rabbit IgG (1:500). Following the final washes, the samples were mounted with mounting medium containing 4',6-diamidino-2'-phenylindole (DAPI) for nuclear counterstaining. Images were captured using a confocal laser scanning microscope.

Statistical analysis
Measurement data were expressed as mean ± standard deviation (S.D.). Quantitative data representing results from three independent replicate assays were taken for analysis. For comparisons between two groups, a t-test was applied, while a one-way analysis of variance (ANOVA) was used for comparisons among multiple groups, followed by Tukey's post hoc test for multiple comparisons. A p-value < 0.05 was considered statistically significant.

Access restricted. Please log in or start a trial to view this content.

Results

Hemin can induce plasma membrane damage, thus it is frequently used for the construction of in vitro cell models of ICH. This study investigated the effects of hemin treatment at varying concentrations and durations on PC12 cell viability, while simultaneously analyzing RKIP protein expression dynamics under corresponding experimental conditions through western blot analysis (Figure 1A). Cell viability was significantly reduced at hemin concentrations of 60 µM or higher (

Access restricted. Please log in or start a trial to view this content.

Discussion

This study investigated the effects and underlying mechanisms of RKIP knockdown on ferroptosis induced by ICH in an in vitro setting. Stimulation of cells with hemin triggers oxidative stress, accompanied by excessive generation of ROS and LPO, thereby promoting ferroptosis. Inhibition of endogenous RKIP expression accelerates the liberated NRF2 to translocate into the nucleus and bind to the Antioxidant Response Element (ARE), initiating the transcription of downstream antioxidant gen...

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgements

This study was supported by grants from the Nantong Municipal Health Commission Project (MS2022015) and the Nantong Science and Technology Bureau Project (JCZ2023022).

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Alexa Fluor 488-labeled Goat Anti-Rabbit IgGBeyotime BiotechA0423
Anti-ACSL4 antibodyCell signaling38493T
Anti-GPX4 antibodyCell signaling59735S
Anti-HO-1 antibodyMedChemExpressHY-P80499
Anti-NRF2 antibodyCell signaling12721T
Anti-RKIP antibodyAbcamab76582
Anti-β-actin antibodyAbcamab179467
BeyoECL PlusBeyotime BiotechP0018M
BSANCM BiotechWB6504-100g
Cell Counting Kit-8Beyotime BiotechC0037
CELLSAVINGNCM BiotechC40050
ChamQ SYBR Color qPCR Master MixVazymeQ411-02
DMSOBeyotime BiotechST038
Fetal Bovine SerumGibcoA5670801
GraphPad Prism
HeminMedChemExpressHY-19424
HiScript Q RT SuperMix for qPCR (+gDNA wiper)VazymeR123-01
HRP-labeled Goat Anti-Mouse IgGThermoC31430100
HRP-labeled Goat Anti-Rabbit IgGThermoC31460100
Lipid Peroxide (LPO) Content Assay KitSolarbioBC5245
LocostatinMedChemExpressHY-W013411A
ML385MedChemExpressHY-100523
Mounting Medium?antifading (with DAPI)SolarbioS2110
NON-FatPowderedMilkSolarbioD8340
PBS (powder?pH7.2-7.4)SolarbioP1010
PC-12AdhNanjing BioChannel BiotechnologyBC-C-RA-005
Penicillin-Streptomycin LiquidSolarbioP1400
PRMI-1640GibcoA1049101
Protease and phosphatase inhibitor cocktail for general use, 50xBeyotime BiotechP1045
Protein MarkerThermo26617
PVDF MilliporeRIKB43638
Reactive Oxygen Species Assay KitSolarbioCA1410
RIPA buffer (high)SolarbioR0010
SDS-PAGE Gel Quick Preparation KitEpizymePG110
SDS-PAGE Sample Loading Buffer, 5xBeyotime BiotechP0015
TritonX-100SolarbioIT9100
TRIzolThermo15596018CN
Trypsin-EDTA solution?0.25% (without phenol red)SolarbioT1300

References

  1. Puy, L., et al. Intracerebral haemorrhage. Nat Rev Dis Primers. 9 (1), 14(2023).
  2. Shao, A., Zhu, Z., Li, L., Zhang, S., Zhang, J. Emerging therapeutic targets associated with the immune system in patients with intracerebral haemorrhage (ICH): from mechanisms to translation. EBioMedicine. 45, 615-623 (2019).
  3. Jiang, X., Stockwell, B. R., Conrad, M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 22 (4), 266-282 (2021).
  4. Wenzel, S. E., et al. PEBP1 wardens ferroptosis by enabling lipoxygenase generation of lipid death signals. Cell. 171 (3), 628-641 (2017).
  5. Beshir, A. B., Argueta, C. E., Menikarachchi, L. C., Gascón, J. A., Fenteany, G. Locostatin disrupts association of Raf kinase inhibitor protein with binding proteins by modifying a conserved histidine residue in the ligand-binding pocket. Forum Immunopathol Dis Therap. 2 (1), 47-58 (2011).
  6. Janjusevic, M., et al. a disrupter of Raf kinase inhibitor protein, inhibits extracellular matrix production, proliferation, and migration in human uterine leiomyoma and myometrial cells. Fertil Steril. 106 (6), 1530-1538 (2016).
  7. Xiao, Z., et al. Reduction of lactoferrin aggravates neuronal ferroptosis after intracerebral hemorrhagic stroke in hyperglycemic mice. Redox Biol. 50, 102256(2022).
  8. Li, Q., et al. Inhibition of neuronal ferroptosis protects hemorrhagic brain. JCI Insight. 2 (7), e90777(2017).
  9. Zhou, Z. X., et al. Withaferin A inhibits ferroptosis and protects against intracerebral hemorrhage. Neural Regen Res. 18 (6), 1308-1315 (2023).
  10. Sun, Y., Li, Q., Guo, H., He, Q. Ferroptosis and iron metabolism after intracerebral hemorrhage. Cells. 12 (1), 90(2022).
  11. Duan, L., et al. Baicalin inhibits ferroptosis in intracerebral hemorrhage. Front Pharmacol. 12, 629379(2021).
  12. Wang, Y., Wu, S., Li, Q., Sun, H., Wang, H. Pharmacological inhibition of ferroptosis as a therapeutic target for neurodegenerative diseases and strokes. Adv Sci (Wein)h. 10 (24), e2300325(2023).
  13. Dodson, M., Castro-Portuguez, R., Zhang, D. D. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol. 23, 101107(2019).
  14. Xiang, Y., Song, X., Long, D. Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases. Arch Toxicol. 98 (3), 579-615 (2024).
  15. Anandhan, A., et al. NRF2 controls iron homeostasis and ferroptosis through HERC2 and VAMP8. Sci Adv. 9 (5), eade9585(2023).
  16. Fan, Z., et al. Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis. Oncogenesis. 6 (8), e371(2017).
  17. Tu, W., Wang, H., Li, S., Liu, Q., Sha, H. The anti-inflammatory and anti-oxidant mechanisms of the Keap1/Nrf2/ARE signaling pathway in chronic diseases. Aging Dis. 10 (3), 637-651 (2019).
  18. Sun, Y. Y., et al. Remote ischemic conditioning attenuates oxidative stress and inflammation via the Nrf2/HO-1 pathway in MCAO mice. Redox Biol. 66, 102852(2023).
  19. Ge, M., et al. Brg1-mediated Nrf2/HO-1 pathway activation alleviates hepatic ischemia-reperfusion injury. Cell Death Dis. 8 (6), e2841(2017).
  20. Wang, H., et al. VDR activation attenuates renal tubular epithelial cell ferroptosis by regulating Nrf2/HO-1 signaling pathway in diabetic nephropathy. Adv Sci (Weinh). 11 (10), e2305563(2024).
  21. Lin, Q., et al. Mitophagy alleviates cisplatin-induced renal tubular epithelial cell ferroptosis through ROS/HO-1/GPX4 axis. Int J Biol Sci. 19 (4), 1192-1210 (2023).
  22. Jiang, T., et al. Gastrodin protects against glutamate-induced ferroptosis in HT-22 cells through Nrf2/HO-1 signaling pathway. Toxicol In Vitro. 62, 104715(2020).
  23. Gong, F., et al. Trehalose inhibits ferroptosis via NRF2/HO-1 pathway and promotes functional recovery in mice with spinal cord injury. Aging (Albany NY). 14 (7), 3216-3232 (2022).
  24. Luo, L., et al. Astaxanthin attenuates ferroptosis via Keap1-Nrf2/HO-1 signaling pathways in LPS-induced acute lung injury. Life Sci. 311 (Pt A), 121091(2022).
  25. Zhao, J., et al. PEBP1 acts as a rheostat between prosurvival autophagy and ferroptotic death in asthmatic epithelial cells. Proc Natl Acad Sci U S A. 117 (25), 14376-14385 (2020).
  26. Wang, H., Xu, L., Tang, X., Jiang, Z., Feng, X. Lipid peroxidation-induced ferroptosis as a therapeutic target for mitigating neuronal injury and inflammation in sepsis-associated encephalopathy: insights into the hippocampal PEBP1/15-LOX/GPX4 pathway. Lipids Health Dis. 23 (1), 128(2024).
  27. Manivarma, T., et al. Membrane regulation of 15LOX-1/PEBP1 complex prompts the generation of ferroptotic signals, oxygenated PEs. Free Radic Biol Med. 208, 458-467 (2023).
  28. Huang, W., et al. Downregulation of RKIP promotes radioresistance of nasopharyngeal carcinoma by activating NRF2/NQO1 axis via downregulating miR-450b-5p. Cell Death Dis. 11 (7), 504(2020).
  29. Al-Mulla, F., Bitar, M. S., Feng, J., Park, S., Yeung, K. C. A new model for Raf kinase inhibitory protein induced chemotherapeutic resistance. PLoS One. 7 (1), e29532(2012).
  30. Zuo, H., et al. RKIP-mediated NF-κB signaling is involved in ELF-MF-mediated improvement in AD rat. Int J Med Sci. 15 (14), 1658-1666 (2018).
  31. Liu, H., et al. RKIP promotes cisplatin-induced gastric cancer cell death through NF-κB/Snail pathway. Tumour Biol. 36 (3), 1445-1453 (2015).
  32. Casper, E. The crosstalk between Nrf2 and NF-κB pathways in coronary artery disease: can it be regulated by SIRT6. Life Sci. 330, 122007(2023).
  33. Hu, B., et al. NF-κB and Keap1 interaction represses Nrf2-mediated antioxidant response in rabbit hemorrhagic disease virus infection. J Virol. 94 (10), e00016-e00020 (2020).

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

NRF2 PathwayHO-1 ActivationPC12 CellsReactive Oxygen SpeciesLipid HydroperoxideGPX4 ExpressionACSL4 Expression